Correlation Between Anebulo Pharmaceuticals and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and ABVC Biopharma, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and ABVC Biopharma.

Diversification Opportunities for Anebulo Pharmaceuticals and ABVC Biopharma

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Anebulo and ABVC is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and ABVC Biopharma

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the ABVC Biopharma. In addition to that, Anebulo Pharmaceuticals is 1.41 times more volatile than ABVC Biopharma. It trades about -0.19 of its total potential returns per unit of risk. ABVC Biopharma is currently generating about -0.15 per unit of volatility. If you would invest  63.00  in ABVC Biopharma on September 4, 2024 and sell it today you would lose (9.00) from holding ABVC Biopharma or give up 14.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Anebulo Pharmaceuticals  vs.  ABVC Biopharma

 Performance 
       Timeline  
Anebulo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Anebulo Pharmaceuticals and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Anebulo Pharmaceuticals and ABVC Biopharma

The main advantage of trading using opposite Anebulo Pharmaceuticals and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Anebulo Pharmaceuticals and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device